Jeffrey Green, MD
Family Medicine · Paris, KYNPI 1114031937
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $854 and has fallen 73.1% since, to $230 in 2025.
Across 199 payments — averaging $15.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$404
- AstraZeneca$370
- Pfizer$298
- Lilly USA, LLC$266
- AbbVie$196
- Boehringer Ingelheim$193
- plus $1K from 29 others
Across 31 payments — averaging $3216.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$89K
- Novo Nordisk AS$10K
What the payments were for
- Food & beverage$3,06197%
- Education$923%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 28 | $404 |
| AstraZeneca | 23 | $370 |
| Pfizer | 16 | $298 |
| Lilly USA, LLC | 17 | $266 |
| AbbVie(2 entities) | 15 | $196 |
| Boehringer Ingelheim | 10 | $193 |
| Novo Nordisk | 12 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $148 |
| Sanofi-aventis U.S. LLC | 9 | $137 |
| Novartis | 7 | $107 |
| GSK | 5 | $85 |
| Exact Sciences | 5 | $81 |
| Kowa Pharmaceuticals America, Inc. | 4 | $58 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| Amgen | 2 | $45 |
| Verona Pharma, Inc. | 2 | $44 |
| Eisai Inc. | 3 | $40 |
| Gilead | 2 | $38 |
| Abbott | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 3 | $36 |
| Halozyme Inc | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Corcept Therapeutics | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Aimmune Therapeutics, Inc. | 2 | $28 |
| Merck | 2 | $26 |
| Sanofi Pasteur Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Bayer | 1 | $15 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
| Johnson & Johnson | 1 | $14 |
| Lucid Diagnostics Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$3,153 in reported general payments places this provider in the 75th percentile of 1,559 family medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 230 | $171,794 |
| JardianceEmpagliflozin | 68 | $86,845 |
| OzempicSemaglutide | 59 | $79,330 |
| JanuviaSitagliptin Phosphate | 37 | $42,778 |
| NuplazidPimavanserin Tartrate | 18 | $42,310 |
| XareltoRivaroxaban | 51 | $41,970 |
| ZenpepLipase/Protease/Amylase | 20 | $38,204 |
| MounjaroTirzepatide | 24 | $32,295 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 42 | $30,286 |
| FarxigaDapagliflozin Propanediol | 34 | $24,686 |
| LinzessLinaclotide | 31 | $23,307 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 23 | $20,720 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 15 | $18,881 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $15,983 |
| JanumetSitagliptin Phos/Metformin Hcl | 17 | $15,049 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $298 | $171,794230 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $193 | $93,10181 claims |
| Novo NordiskOzempic | $172 | $79,33059 claims |
| MerckJanuvia, Janumet, Janumet Xr | $26 | $65,49068 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Brilinta | $370 | $61,101112 claims |
| Lilly USA, LLCMounjaro, Trulicity | $266 | $47,04136 claims |
| Johnson & JohnsonXarelto | $14 | $41,97051 claims |
| Aimmune Therapeutics, Inc.Zenpep | $28 | $38,20420 claims |
| GSKTrelegy Ellipta | $85 | $30,28642 claims |
| AbbVieLinzess | $196 | $23,30731 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $404 | $10,14911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Paris
- Christopher RhyneLouisville$933K
- John RichardLexington$226K
- James TurnboPaducah$124K
- Edward SchumannFlorence$79K
- Ronald KoffNew Castle$71K
- Suraj GathaniLouisville$69K
- Bradley GrayFlorence$51K
- Jackie KazeeAshland$45K
- Mandy WhittLouisville$38K
- Derek JonesAshland$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.